PLX · Protalix BioTherapeutics, Inc.
$2.48
+0.08 (+3.33%)
At close · Aug 26
Market Cap
$199.82M
Shares
80.57M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-25 | — | |
| 8-K | 2026-05-21 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| DEF 14A | 2026-04-30 | 2026-06-25 | |
| 8-K | 2026-03-18 | — | |
| 10-K | 2026-03-18 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-11 | — | |
| 8-K | 2026-01-30 | — | |
| 8-K | 2026-01-05 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-17 | — | |
| 8-K | 2025-08-22 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-07-21 | 2025-06-13 | |
| 8-K | 2025-06-26 | — | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-30 | 2025-06-26 | |
| 8-K | 2025-04-23 | 2025-04-21 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2024-12-31 | 2024-12-27 | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-10-25 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-06-28 | 2024-06-27 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-10 | — | |
| DEF 14A | 2024-04-29 | 2024-06-27 | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2023-12-26 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-09-12 | — | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-08-07 | — |
Showing 1–50 of 128 filings
Key facts
CIK
1006281
CUSIP
74365A309
13F (30d)
89 filings
87 filers
Visit website
Investor relations